Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in Saudi Arabia
3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 4CompletedAsciminib Roll-over Study
- Where
- Riyadh
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 3Not yet taking people in Saudi ArabiaA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Jeddah, Riyadh
- Age
- 18 years and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00 - No phaseSuspendedProject: Every Child for Younger Patients With Cancer
- Where
- Riyadh
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244